Ziegler Capital Management, LLC Y M Abs Therapeutics, Inc. Transaction History
Ziegler Capital Management, LLC
- $2.84 Billion
- Q1 2024
A detailed history of Ziegler Capital Management, LLC transactions in Y M Abs Therapeutics, Inc. stock. As of the latest transaction made, Ziegler Capital Management, LLC holds 35,461 shares of YMAB stock, worth $305,319. This represents 0.02% of its overall portfolio holdings.
Number of Shares
35,461Holding current value
$305,319% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding YMAB
# of Institutions
33Shares Held
14.4MCall Options Held
24KPut Options Held
0-
Acorn Capital Advisors, LLC New York, NY3.42MShares$29.4 Million10.09% of portfolio
-
Black Rock Inc. New York, NY2.94MShares$25.3 Million0.0% of portfolio
-
Memorial Sloan Kettering Cancer Center New York, NY191KShares$1.65 Million4.24% of portfolio
-
Jacobs Levy Equity Management, Inc Florham Park, NJ143KShares$1.23 Million0.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL112KShares$968,4780.0% of portfolio
About Y-mAbs Therapeutics, Inc.
- Ticker YMAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,719,500
- Market Cap $376M
- Description
- Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...